Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects

University of British Columbia

$113,675.00

Platform technology for blood diagnostics integrating microneedle blood sampling and quantum-dot based multiplexed assays

EF 2018-19

Résumé
Blood is the most useful sample fluid for lab medicine and diagnostics. It is most often*obtained by inserting a needle in a vein in the arm (venipuncture). In the US, over 2 billion*venipunctures are performed annually and is a technique that requires skilled personnel.*Venipuncture is often associated with pain, discomfort and bruising, and is most difficult in*persons with small, fragile, or ""deep"" veins (e.g. obesity), in babies, and when repeated*sampling is needed. We propose an alternative that will minimize discomfort and bruising, will*not require highly skilled personnel, and will be safe and easy.*Our project combines an array of tiny needles (microneedles) that can be placed as a ""patch""*on the surface of the skin to collect small amounts of blood. The microneedles cause little*discomfort, have a very low risk of causing bruising, and can be applied by the patient or a*non-medical person. As the blood is collected, it will flow into a ""lab-on-a-chip-on-a-phone""*device, where the blood tests will automatically be performed using new and highly sensitive*fluorescent probes. These tests will include immunoassays for protein biomarkers associated*with cardiovascular disease, partially in collaboration with our industry partner, as well as*assays of the activities of blood coagulation factors. Results from this platform can be*immediately and electronically sent to the patient and physician.*This research builds on successful preliminary applications with the microneedle arrays and*fluorescent probes separately. We will now further develop and combine these innovative*methods for a much-needed medical use, make comparisons to the standard venipuncture*approach, and ultimately plan to perform many tests simultaneously with the devices. The*benefits over current methods will be substantial: a painless, safe and user-friendly way to*draw and test blood, with rapid reporting of results to health professionals and patients.
Programme
Collaborative Health Research Projects
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
523793-2018
Name nom
Stoeber, Boris
Department département
Mechanical Engineering
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
113675
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
1
Nb partie
1
Application title
Platform technology for blood diagnostics integrating microneedle blood sampling and quantum-dot based multiplexed assays
Keyword
NSERC
Application summary
Blood is the most useful sample fluid for lab medicine and diagnostics. It is most often*obtained by inserting a needle in a vein in the arm (venipuncture). In the US, over 2 billion*venipunctures are performed annually and is a technique that requires skilled personnel.*Venipuncture is often associated with pain, discomfort and bruising, and is most difficult in*persons with small, fragile, or ""deep"" veins (e.g. obesity), in babies, and when repeated*sampling is needed. We propose an alternative that will minimize discomfort and bruising, will*not require highly skilled personnel, and will be safe and easy.*Our project combines an array of tiny needles (microneedles) that can be placed as a ""patch""*on the surface of the skin to collect small amounts of blood. The microneedles cause little*discomfort, have a very low risk of causing bruising, and can be applied by the patient or a*non-medical person. As the blood is collected, it will flow into a ""lab-on-a-chip-on-a-phone""*device, where the blood tests will automatically be performed using new and highly sensitive*fluorescent probes. These tests will include immunoassays for protein biomarkers associated*with cardiovascular disease, partially in collaboration with our industry partner, as well as*assays of the activities of blood coagulation factors. Results from this platform can be*immediately and electronically sent to the patient and physician.*This research builds on successful preliminary applications with the microneedle arrays and*fluorescent probes separately. We will now further develop and combine these innovative*methods for a much-needed medical use, make comparisons to the standard venipuncture*approach, and ultimately plan to perform many tests simultaneously with the devices. The*benefits over current methods will be substantial: a painless, safe and user-friendly way to*draw and test blood, with rapid reporting of results to health professionals and patients.